Manipal, 25th November 2024:  In a groundbreaking achievement for India’s scientific and healthcare communities, the Manipal Institute of Virology (MIV) has been recognized as an ICMR Collaborating Center of Excellence (ICMR-CCoE) by the Indian Council of Medical Research (ICMR). This prestigious designation underscores MIV’s leadership in virology research, its advanced diagnostic capabilities, and its pivotal role in fostering interdisciplinary collaborations at both national and international levels. The recognition cements MIV’s status as a critical contributor to strengthening India’s biomedical research ecosystem and addressing the nation’s pressing public health challenges.

The recognition as an ICMR-CCoE is a testament to MIV’s outstanding contributions to the field of virology, particularly in the study of emerging infectious diseases, viral diagnostics, and vaccine development. Under the visionary leadership of Dr. Chiranjay Mukhopadhyay, Professor and Director of MIV, the Institute has achieved remarkable milestones in research, diagnostics, and collaboration. Lt Gen (Dr) M D Venkatesh, VSM (Retd), Vice Chancellor, Manipal Academy of Higher Education, Manipal “Manipal Institute of Virology’s recognition as an ICMR Collaborating Center of Excellence is a momentous achievement that underscores our commitment to advancing biomedical research and public health. This distinction reflects the hard work, dedication, and innovation of our team, and reinforces Manipal Academy of Higher Education’s leadership in shaping the future of medical research and healthcare solutions. We are proud to contribute to global health advancements and look forward to fostering collaborations that will have a lasting impact on society”

“Being recognized as an ICMR Collaborating Center of Excellence is a significant milestone for the Manipal Institute of Virology. This honor reflects our unwavering commitment to advancing virology research, strengthening diagnostic capabilities, and addressing public health challenges through collaboration and innovation. As we step into this new role, we aim to contribute even more effectively to India’s health research ecosystem, foster global partnerships, and train the next generation of scientists to tackle emerging infectious diseases and other critical health issues. Together, we can build a healthier, more resilient future”, said Dr. Chiranjay Mukhopadhyay.

One of the key advantages of being designated an ICMR-CCoE is the opportunity for expanded collaborations. MIV has a long history of partnering with leading research institutions, healthcare organizations, and universities across India and abroad. These partnerships have driven its research agenda and ensured that its findings are both scientifically rigorous and aligned with public health needs.

Through its expertise in virology, MIV will play a critical role in disease surveillance, outbreak management, and vaccine development, particularly for diseases like influenza, hepatitis, and other viral infections that pose significant threats to public health. By providing evidence-based research, the Institute will support the development of national health policies and strategies tailored to India’s unique epidemiological landscape.

With the ICMR-CCoE recognition, the Manipal Institute of Virology is positioned to play a pivotal role in advancing India’s status as a global leader in biomedical research. This milestone highlights India’s growing prominence in the global health landscape and reaffirms the country’s commitment to addressing both national and international health challenges.

As MIV continues its work in virology research, public health, and scientific collaboration, the Institute is set to make lasting contributions to the global fight against infectious diseases, ensuring a healthier future for all.